United European Gastroenterology Week has selected the abstract, “Information Necessary to Predict Individual Infliximab (IFX) Pharmacokinetics (PK) in Patients with IBD” as the poster of distinction and will be presented at the poster champ session. Dr. Mould was a contributor to the abstract.
